No Data
ACIU AC Immune
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About AC Immune Company
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Revenue Breakdown
News
Are Options Traders Betting on a Big Move in AC Immune (ACIU) Stock?
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05, 2023 – AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company
AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why
Comments
Daily alerts recap 6/27 🔥🔥 230%+










$Netflix(NFLX.US$$Campbell Soup(CPB.US$$AstraZeneca(AZN.US$$MasterCard(MA.US$$Lordstown Motors(RIDE.US$$AC Immune(ACIU.US$$Paltalk(PALT.US$$Lulus Fashion Lounge(LVLU.US$$Leap Therapeutics(LPTX.US$$Applied Optoelectronics(AAOI.US$$Theriva Biologics(TOVX.US$
...



102914606 : later will jump to 4. U just watch. good luck